Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
329 studies found for:    "Sezary syndrome"
Show Display Options
Download search resultsDownload the search results for:
"Sezary syndrome" (329 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Terminated Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome
Conditions: Sezary Syndrome;   Pruritus
Interventions: Drug: Aprepitant;   Drug: Placebo
2 Terminated Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
Conditions: Mycosis Fungoides;   Sezary Syndrome
Intervention: Drug: HuMax-CD4 (zanolimumab)
3 Completed Immunization Against Tumor Cells in Sezary Syndrome
Conditions: Cutaneous T-cell Lymphoma;   Sezary Syndrome
Intervention: Biological: Autologous Dendritic Cell Vaccine
4 Recruiting Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome
Conditions: Mycosis Fungoides;   Sezary Syndrome
Intervention: Drug: Campath-1H
5 Unknown  Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome
Conditions: Mycosis Fungoides;   Sezary Syndrome
Intervention: Drug: alemtuzumab
6 Not yet recruiting TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome
Conditions: Mycosis Fungoides;   Sézary Syndrome
Interventions: Radiation: TSEB Therapy;   Drug: Brentuximab vedotin
7 Recruiting Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS)
Conditions: Mycosis Fungoides;   Sezary Syndrome;   Lymphoma, T-Cell, Cutaneous
Interventions: Drug: resminostat;   Drug: Placebo
8 Recruiting VircapSeq Virus Detection in Sézary Syndrome
Conditions: Lymphoma, T-Cell, Cutaneous;   Sézary Syndrome
Intervention:
9 Active, not recruiting Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome
Conditions: Recurrent Mycosis Fungoides and Sezary Syndrome;   Stage IB Mycosis Fungoides and Sezary Syndrome;   Stage IIA Mycosis Fungoides and Sezary Syndrome;   Stage IIB Mycosis Fungoides and Sezary Syndrome;   Stage IIIA Mycosis Fungoides and Sezary Syndrome;   Stage IIIB Mycosis Fungoides and Sezary Syndrome;   Stage IVA Mycosis Fungoides and Sezary Syndrome;   Stage IVB Mycosis Fungoides and Sezary Syndrome
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab
10 Terminated Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome
Condition: Lymphoma
Intervention: Drug: temozolomide
11 Completed Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome
Condition: Lymphoma
Intervention: Drug: tretinoin
12 Terminated Interleukin-2 in Treating Patients With Mycosis Fungoides or Sezary Syndrome
Condition: Lymphoma
Intervention: Biological: aldesleukin
13 Active, not recruiting Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome
Condition: Lymphoma
Intervention: Biological: alemtuzumab
14 Not yet recruiting ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
Conditions: Mycosis Fungoides;   Non-Hodgkin's Lymphoma
Intervention:
15 Completed Killer Immunoglobulin-Like Receptor Transcripts Expression for the Diagnosis of Epidermotropic Cutaneous T Cell Lymphoma
Conditions: Mycosis Fungicides;   Sezary Syndrome;   Dermatitis;   Dermatitis, Exfoliative
Intervention: Other: Detection of KIR receptor by RT PCR
16 Active, not recruiting Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome
Condition: Lymphoma
Intervention: Drug: lenalidomide
17 Completed Effect of Denileukin Diftitox on Immune System in CTCL Patients
Conditions: Cutaneous T-cell Lymphoma;   Sezary Syndrome;   Mycosis Fungoides
Intervention:
18 Active, not recruiting Pilot Study of Brentuximab Vedotin (SGN-35) in Patients With MF With Variable CD30 Expression Level
Conditions: Lymphoma, Non-Hodgkin;   Cutaneous Lymphoma;   Cutaneous T Cell Lymphoma;   Mycosis Fungoides;   Sezary Syndrome
Intervention: Drug: Brentuximab vedotin
19 Terminated Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome
Condition: Lymphoma
Interventions: Drug: Gemcitabine;   Drug: Pemetrexed
20 Completed In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL)
Conditions: Cutaneous T-cell Lymphoma;   Sezary Syndrome;   Mycosis Fungoides
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.